4//SEC Filing
ANDRZEJEWSKI STEPHEN J 4
Accession 0001209191-10-001345
CIK 0001047699other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:47 PM ET
Size
7.4 KB
Accession
0001209191-10-001345
Insider Transaction Report
Form 4
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2009-12-31+21,120→ 171,242 total - Exercise/Conversion
Long-Term Performance Unit
2009-12-31−21,120→ 0 totalExp: 2009-12-31→ Common Stock (21,120 underlying)
Footnotes (1)
- [F1]Each Long-Term Performance Unit represented a contingent right to receive a share of King Pharmaceuticals, Inc. common stock if the reporting person remained employed by King Pharmaceuticals, Inc. during the two-year vesting period that ended on December 31, 2009.
Documents
Issuer
KING PHARMACEUTICALS INC
CIK 0001047699
Entity typeother
Related Parties
1- filerCIK 0001321648
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:47 PM ET
- Size
- 7.4 KB